Bio-Techne TECH Service — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's service — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's service — revenue?
- Bio-Techne (TECH) reported service — revenue of $21.45M in Q1 2026.
- How has Bio-Techne's service — revenue changed year-over-year?
- Bio-Techne's service — revenue decreased by 21.3% year-over-year, from $27.25M to $21.45M.
- What is the long-term trend for Bio-Techne's service — revenue?
- Over 4 years (2021 to 2025), Bio-Techne's service — revenue has grown at a 13.8% compound annual growth rate (CAGR), from $66.42M to $111.57M.
- What does service — revenue mean?
- The total revenue earned from providing services to customers, excluding taxes.
- How do you interpret service — revenue?
- An increase indicates growing demand for the company's service offerings and potential expansion of the installed base, while a decrease may suggest reduced service utilization or contract churn.
- How does service — revenue compare across companies?
- Peers in the life sciences and diagnostic tools sector typically report this as service revenue, often benchmarking it against total segment revenue to measure the mix of recurring service income versus one-time product sales.